UK-101 is a potent and selective inhibitor of the immunoproteasome subunit β1i (LMP2) (IC50 = 104 nM), with 144-fold and 10-fold selectivity over the β1c (IC50 = 15 μM) and β5 (IC50 = 1 μM) subunits, respectively; it can induce apoptosis and is useful in research related to prostate cancer.